anmelden
Pacific Biosciences of California Aktie
1,23
EUR
-0,03
EUR
-2,27
%
1,44
USD
-0,07
USD
-4,33
%
Pacific Biosciences of California jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Pacific Biosciences of California Aktie Analyse
| 19.10.18 | Pacific Biosciences of California Outperform | Cowen and Company, LLC | |
| 03.11.16 | Pacific Biosciences of California Buy | Cantor Fitzgerald | |
| 15.04.16 | Pacific Biosciences of California Overweight | First Analysis Securities | |
| 04.02.15 | Pacific Biosciences of California Buy | Maxim Group |
Werbung
Werbung